Genomic index of sensitivity to endocrine therapy for breast cancer. - Wikidata - thesis-toulmin - TriplyDB

Genomic index of sensitivity to endocrine therapy for breast cancer.

Genomic index of sensitivity to endocrine therapy for breast cancer.

http://www.wikidata.org/entity/Q34193932

about

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection multiClust: An R-package for Identifying Biologically Relevant Clusters in Cancer Transcriptome Profiles Genomic profiling in luminal breast cancer Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer 'Omic approaches to preventing or managing metastatic breast cancer Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen.A data similarity-based strategy for meta-analysis of transcriptional profiles in cancer.Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis.Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.Double-edged role of G protein-coupled estrogen receptor 1 in breast cancer prognosis: an analysis of 167 breast cancer samples and online data sets Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer Imputing gene expression to maximize platform compatibility.mAPC-GibbsOS: an integrated approach for robust identification of gene regulatory networks.Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue.Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?Cross-study validation for the assessment of prediction algorithms.Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis DACH1 suppresses breast cancer as a negative regulator of CD44.Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes Visualising the cross-level relationships between pathological and physiological processes and gene expression: analyses of haematological diseases Predictive and prognostic biomarkers with therapeutic targets in breast, colorectal, and non-small cell lung cancers: a systemic review of current development, evidence, and recommendation.NF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer Determination of minimum training sample size for microarray-based cancer outcome prediction-an empirical assessment.Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer.A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences.Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERα-positive breast cancer.Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatment A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction.A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers.A three-gene model to robustly identify breast cancer molecular subtypes Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.TGFβ isoforms and receptors mRNA expression in breast tumours: prognostic value and clinical implications

P2860

Q24605762-188A5BBC-1BE4-4813-9EE5-54E7DFA31584 Q26744071-EDAE9F90-F157-4EB1-9502-EF7808DB086D Q26862681-733454FA-14CD-4784-9550-2C07C5427D51 Q28264693-343A11B1-940C-4B8A-B0F9-70671A46D6F2 Q28730572-AFB39A49-5F3F-4289-A1B6-1B986C22F45E Q30245184-D56CACC7-9A1C-423C-9B58-BB896BDCA2E4 Q30487036-C6C37E83-6AEC-4155-AFC2-DF69BECF2B8B Q30535835-FF83D68A-F6C0-49F9-8D75-BAAC1254E289 Q30587056-BB654EBC-EEB5-45B3-89B5-6B6D4489997C Q30838620-F96B50F2-6F02-4007-8661-39538F25C560 Q31011613-8EA96838-81A1-4E7C-9E5D-22F322D331B2 Q31141334-2E54FB26-9D73-4A40-9170-CA4D3EDE7252 Q33555064-60C649F9-E87A-4BEE-8719-2E57FE6CA08F Q33614031-679E26EA-1998-4343-AB7A-D9F2873A7C6A Q33640925-E68809ED-6DCF-49A7-82E1-5FD25E11FE6A Q33723629-4A31B3D8-F6AA-4D3C-BCC5-13D077EB327A Q33751916-E764C521-EA50-4CA0-87B6-A0D36519C82C Q33760371-14F3B54F-06A8-4B51-A54D-74361280DD70 Q33821114-84467A7A-4BBA-4F7B-A780-A711CE90B557 Q33849252-993C9563-9E1A-4387-BB7F-E048D6AAAA8E Q34374191-AAC3B4EC-70A5-419C-B7E2-E85CDC279D4D Q34542542-69E26447-77E9-4D69-878B-85B83A26202B Q34620545-F8451E0F-7B03-49DC-8210-56E5F350C905 Q34745409-1F3B8044-CD04-4489-92DC-54945A7305A4 Q34827732-E056E1D1-5B85-4642-BAB4-0615DFFE717B Q34854816-A65D2741-2997-4AF0-AEC8-10088830B676 Q34895090-10E68D08-3D64-4933-8B11-735A428EFD96 Q35106947-65955F7D-34E8-4DBD-B7ED-C0ABA9F2624A Q35182439-18B4B3C2-D34D-43F9-B0F3-BE80AAA0B8B8 Q35226519-3C32077A-AD9A-4DF7-A748-DBFFBC9DAC01 Q35386137-DADB4668-C137-412B-8821-311DD0977814 Q35402584-788340F1-C28D-4872-89C2-8C295F01E71A Q35501973-F2912958-3837-4DB3-BC9D-21EC297FA9BD Q35558070-D2535462-C870-42BA-809B-45420F6B6E72 Q35566213-D5E43759-F3DE-4FF4-B275-1C08FCD83102 Q35626576-4A8A414B-6CEF-40E9-B433-AAB8490A1729 Q35769036-2D00910B-A8C7-4EED-B97A-FD192F8E4FA8 Q35799611-1296B432-5A4B-42BD-BC29-394021308D17 Q35799667-025A352B-3657-41CD-A916-31D258DE532B Q35878410-8A6807C5-C09B-489A-AE61-8A045AC19BEE

P2860

Genomic index of sensitivity to endocrine therapy for breast cancer.

http://www.wikidata.org/entity/Q34193932

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Genomic index of sensitivity to endocrine therapy for breast cancer.

@ast

Genomic index of sensitivity to endocrine therapy for breast cancer.

@en

Genomic index of sensitivity to endocrine therapy for breast cancer.

@nl

type

label

Genomic index of sensitivity to endocrine therapy for breast cancer.

@ast

Genomic index of sensitivity to endocrine therapy for breast cancer.

@en

Genomic index of sensitivity to endocrine therapy for breast cancer.

@nl

prefLabel

Genomic index of sensitivity to endocrine therapy for breast cancer.

@ast

Genomic index of sensitivity to endocrine therapy for breast cancer.

@en

Genomic index of sensitivity to endocrine therapy for breast cancer.

@nl

P1433

Q34193932-CD3F6253-CEB7-47B8-B80E-4509572974FD

P1476

Q34193932-CAFE7308-C8EF-4F56-99DD-200B70171898

P2093

Q34193932-33568743-FC8C-401F-B14C-DD608110DDEA

Q34193932-5B264976-F640-430D-AC59-33C4A07E8662

Q34193932-5CE2CC87-57FB-400A-9C70-6523465E7A84

Q34193932-6E063421-65E6-46A6-BEF8-8AAEA3A3AE3C

Q34193932-9069DB63-38E1-463B-AAB8-167C87302156

Q34193932-B239378D-A9B5-4F30-AC25-29F77BD4A051

Q34193932-B3C3780D-1492-4AC4-B681-3429B5210C60

Q34193932-BAC6231E-86CF-497D-AAA7-0034A98DBEF5

Q34193932-C0F9EC1C-9AB8-4EF2-8002-9B14770EBBF7

Q34193932-C6743009-898E-41E6-A979-3FFBD28F4539

P2860

Q34193932-055BABBD-C983-418B-824C-FE10C710DDCF

Q34193932-0C0BE502-A295-4109-BE4F-937F32B8830E

Q34193932-3220CB6E-A9DC-4EA1-962B-4E619446068B

Q34193932-3426DEC4-900E-41B0-82DF-6640E97B42DF

Q34193932-400CAD3C-74C5-4F3F-ADA6-A446635DB2C8

Q34193932-50EBE32D-C489-403A-B518-EA946175FEDB

Q34193932-5885E586-8965-4825-81BC-1E2838000107

Q34193932-5921C75A-E12E-40F7-8F52-5A611786ADFE

Q34193932-62BAC2C0-301F-4A64-A462-7F18E984260E

Q34193932-6C459EF4-7784-4454-B2B2-84C99E5F8D3F

P304

Q34193932-F905E035-7FFB-4B34-AF1A-6C3B42B9CA1E

P31

Q34193932-4456A1C4-2819-409E-9397-1B6E756D769C

P356

Q34193932-0DEA97BF-C72D-41B7-9E91-64B82401ADEE

P407

Q34193932-CCBAF946-6C48-4B52-BC7D-2576D78FCF56

P433

Q34193932-06738222-0A1D-4B56-93CC-7A89F453261D

P478

Q34193932-5A110E2E-0987-4064-91D6-3847E910A1CB

P50

Q34193932-713653E4-6D77-4317-8625-B9E299494C2A

Q34193932-926D2040-D212-42B5-AFB1-CE1DC63D15ED

Q34193932-C79510ED-ADD2-4130-8918-B7E11F3AAF26

Q34193932-E9E99D01-8AFD-479D-99CD-FBC079D4348F

P577

Q34193932-0F45BBA4-BB26-48F1-8D41-042D9E44E54B

P698

Q34193932-D7178993-291F-40D4-9CE5-F4B2CE444C07

P932

Q34193932-B6930DAC-968A-4D99-8AEF-DC661379A1B3

P356

JCO.2010.28.4273

P1433

Journal of Clinical Oncology

P1476

Genomic index of sensitivity to endocrine therapy for breast cancer

@en

P2093

Christian Marth

http://www.w3.org/2001/XMLSchema#string

Christos Sotiriou

http://www.w3.org/2001/XMLSchema#string

Daniel J Booser

http://www.w3.org/2001/XMLSchema#string

Florentia Peintinger

http://www.w3.org/2001/XMLSchema#string

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Guenter Daxenbichler

http://www.w3.org/2001/XMLSchema#string

Julien Domont

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

Suzette Delaloge

http://www.w3.org/2001/XMLSchema#string

Thomas Bauernhofer

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Gene expression profiling predicts clinical outcome of breast cancer

Molecular portraits of human breast tumours

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12)

Involvement of steroid hormone and growth factor cross-talk in endocrine response in breast cancer.

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Concordance among gene-expression-based predictors for breast cancer.

P304

4111-4119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2010.28.4273

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Christine Desmedt

Christos Hatzis

P577

2010-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20697068

http://www.w3.org/2001/XMLSchema#string

P932

2953969

http://www.w3.org/2001/XMLSchema#string